percutaneous ventricular assist device News
-
Supira Medical, A Shifamed Portfolio Company, Closes $30m in an Oversubscribed Series C Financing
Company to Advance its Next Generation Percutaneous Ventricular Assist Device Los Gatos, Calif., February 28, 2022 – Supira Medical, Inc., a Shifamed portfolio company that is focused on developing a next-generation solution for temporary mechanical circulatory support, announced today the closing of $30M in Series C financing. Led by Cormorant Asset Management and The Capital Partnership ...
-
Supira Medical, A Shifamed Portfolio Company, Closes $35M in Series B Financing
Company Appoints Seasoned Medtech Executive as President and CEO CAMPBELL, Calif., March 5, 2020 – Supira Medical, formed by Shifamed as part of its medical innovation hub, announced today the closing of $35M in Series B financing. Officially closed on February 25, the financing was led by Cormorant Asset Management with participation from The Capital Partnership (TCP), 415 CAPITAL, AMED ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you